
The European Respiratory Review (ERR) is a leading peer-reviewed journal that plays a vital role in the dissemination of knowledge in respiratory medicine. Published by the European Respiratory Society (ERS), the journal is dedicated to providing high-quality review articles that summarize and interpret the latest developments in the field. With a global readership of clinicians, researchers, and healthcare professionals, ERR continues to impact the diagnosis, treatment, and management of respiratory diseases.
Founded to serve as a platform for continuous professional development, the European Respiratory Review bridges the gap between cutting-edge research and clinical application. Unlike original research journals, ERR focuses primarily on review articles, expert opinions, and guidelines, making it an essential tool for staying updated on rapidly evolving respiratory science.
The journal covers a broad spectrum of topics, including but not limited to asthma, chronic obstructive pulmonary disease (COPD), lung cancer, pulmonary hypertension, sleep-related breathing disorders, and infectious diseases such as tuberculosis and COVID-19. These comprehensive reviews provide insight into emerging therapies, diagnostic innovations, and long-term management strategies.
The European Respiratory Review is indexed in major databases like PubMed, Scopus, and Web of Science, ensuring high visibility and academic credibility. This indexing enables healthcare professionals worldwide to access the latest evidence-based updates in respiratory medicine. Moreover, the journal follows a rigorous peer-review process that ensures each article meets the highest standards of scientific integrity and clinical relevance.
One of the standout features of ERR is its open-access policy. All articles are freely available online, promoting equitable access to knowledge for clinicians and researchers, regardless of their geographic or economic background. This aligns with the ERS’s mission of improving lung health globally.
ERR has adopted a continuous publication model, meaning that accepted articles are published online as soon as they are ready, rather than waiting for scheduled issues. This ensures timely dissemination of important information in a fast-moving field like respiratory medicine.
The journal benefits from contributions by renowned international experts in pulmonology and respiratory care. These authors provide in-depth reviews supported by up-to-date references and real-world clinical experience. By aggregating knowledge from across the globe, ERR offers a well-rounded perspective that is relevant for a diverse audience.
Whether you’re a pulmonologist, a general practitioner, a respiratory therapist, or a researcher in medical science, the European Respiratory Review is an invaluable resource. The journal helps you stay informed about best practices, novel treatment approaches, and key challenges in the respiratory domain.
The European Respiratory Review (ERR) is a highly respected, peer-reviewed medical journal dedicated to the field of respiratory medicine. Published by the European Respiratory Society (ERS), the journal serves as a crucial platform for clinicians, researchers, and healthcare professionals who are involved in the diagnosis, treatment, and management of respiratory diseases.
The European Respiratory Review is an open-access journal that publishes high-quality articles related to respiratory health. These include state-of-the-art reviews, educational articles, clinical guidelines, editorials, and conference reports. The journal’s content is designed to bridge the gap between research and clinical practice, making it an essential resource for anyone interested in the latest advancements in pulmonology.
ERR covers a wide range of topics in respiratory medicine, such as:
Asthma and Allergies
Chronic Obstructive Pulmonary Disease (COPD)
Pulmonary Hypertension
Interstitial Lung Disease (ILD)
Sleep-Disordered Breathing
Lung Cancer
Infectious Diseases of the Lung, including Tuberculosis
COVID-19 and its impact on respiratory health
By focusing on these key areas, the journal supports the continuous education of medical professionals and helps shape the future of respiratory care.
Open Access and Free to Read: Unlike many scientific journals, the European Respiratory Review provides free access to all its articles, promoting global knowledge sharing and medical education.
Expert Contributions: Articles are authored by leading experts in the field, ensuring accuracy, credibility, and clinical relevance.
High Impact and Visibility: As an official publication of the European Respiratory Society, the journal has strong visibility in academic and clinical communities worldwide. It is indexed in PubMed, Scopus, and Google Scholar, making it easily discoverable.
Timely and Relevant Content: The journal stays up-to-date with emerging trends, such as digital health tools, AI in diagnostics, and long-term effects of post-COVID respiratory symptoms.
You can read the latest articles from the European Respiratory Review directly on the official ERS website. With its user-friendly interface, healthcare professionals, researchers, and students can quickly search for specific topics or browse through issues by date.
The European Respiratory Review (ERR) is a prestigious, peer-reviewed journal published by the European Respiratory Society (ERS). As an open-access publication, the ERR is a vital resource for healthcare professionals, researchers, and academicians in the field of respiratory medicine. Its primary mission is to promote the dissemination of knowledge and support the continuing education of respiratory specialists worldwide.
The scope of the European Respiratory Review spans a wide range of topics within the respiratory and pulmonary domain. This includes, but is not limited to:
Pulmonary diseases such as asthma, COPD (Chronic Obstructive Pulmonary Disease), and interstitial lung diseases.
Respiratory infections, including tuberculosis and pneumonia.
Lung cancer and thoracic oncology.
Critical care and sleep medicine, focusing on conditions like sleep apnea and respiratory failure.
Pulmonary vascular diseases such as pulmonary hypertension.
Pediatric respiratory conditions, offering insights into diseases affecting younger populations.
Occupational and environmental lung diseases, addressing the impact of external factors on respiratory health.
This wide scope ensures that the ERR remains relevant to a broad audience, from clinicians in practice to researchers in academic settings.
Unlike traditional research journals, the European Respiratory Review emphasizes comprehensive review articles, editorials, and position statements. These are designed to summarize current knowledge, provide clinical guidance, and stimulate further discussion and research. The journal plays a key role in translating complex research into accessible insights for daily clinical practice.
The ERR upholds rigorous peer-review standards to ensure the quality and reliability of its content. Articles are selected based on their scientific merit, relevance to current respiratory issues, and educational value. This commitment to quality has made the journal a trusted source of knowledge for over a decade.
One of the key strengths of the European Respiratory Review is its open-access policy, which allows readers from across the world to access high-quality respiratory medicine content free of charge. This democratization of knowledge is particularly important for professionals in low- and middle-income countries, where access to paid journals may be limited.